http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103592391-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
filingDate 2013-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103592391-B
titleOfInvention The content assaying method of Specnuezhenide in Zhenqi Fuzheng prepn
abstract The invention discloses the content assaying method of Specnuezhenide in a kind of Zhenqi Fuzheng prepn, it is with Specnuezhenide reference substance for contrast, with methyl alcohol: water/0.01% ~ 5% phosphate aqueous solution/0.01% ~ 5% glacial acetic acid/0.01% ~ 0.5% aqueous formic acid=20 ~ 50:80 ~ 50 or acetonitrile: water/0.01% ~ 5% phosphate aqueous solution/0.01% ~ 5% glacial acetic acid/0.01% ~ 0.5% aqueous formic acid=5 ~ 35:95 ~ 65 are the high performance liquid chromatography of mobile phase.Compared with prior art, the present invention is measured the content of Specnuezhenide composition in Zhenqi Fuzheng prepn by high performance liquid chromatography, the specificity of described method is strong, precision is high, reproducible, the recovery is high, stability is high, measurement result is accurate, reach the object effectively controlling drug quality, ensure that the safe, effective of the stable of product quality and clinical application.
priorityDate 2013-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID458695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID458695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415783739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154497862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6440999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426108640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350

Total number of triples: 35.